Please login to the form below

Not currently logged in
Email:
Password:

Parexel expands global regulatory services team

Robert Iser, Dr Bob Desai and Dr Chang Lee join the biopharma services firm

US-based biopharmaceutical services company Parexel has bolstered its regulatory services team with the addition of three senior executives from the FDA and pharma.

Robert Iser joins Parexel as its vice president of regulatory consulting service from his post as director of the Food and Drug Administration’s (FDA) Office of Process and Facilities.

With more than 14 years’ experience with the US regulators, Iser reviewed product quality and assessed manufacturing processes and pre-approval inspections, and was responsible for developing and implementing CMC guidance.

Prior to joining the FDA, Iser spent seven years in the pharmaceutical industry managing quality systems, and supporting manufacturing process development, scale-up and validation.

His new role will see him focus on helping clients avoid market delays due to compliance or quality problems.

Meanwhile, Parexel has also appointed Dr Bob Desai as its vice president of consulting, technical oncology. He brings a decade of experience leading global oncology and biologic drug development programmes for Astellas, Pfizer, Hospira, Abbott and AbbVie.

His previous work has extended to all phases of oncology drug development and product classes from chemical compounds to recombinant biologics.

Dr Chang Lee takes up the position of vice president of consulting, APAC, bringing both industry and regulatory agency experience to his new role. He has previously worked for the likes of Novartis, Igenix and the FDA.

Dr Paul Bridges, worldwide head of Parexel consulting, said: “These new team members will contribute to our mission of helping clients take their products through development swiftly, successfully, and profitability, and ultimately, to the patients who need them most.”

30th November 2017

From: Sales, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

Market Shaping for Better Healthcare Decisions
82% of healthcare business professionals agreed that it is important to get market shaping right to achieve future brand success....
launch engagement
Launch engagement
How the pandemic is forcing a fresh focus on the human touch and fresh thinking about engagement...
Everything you need to know about patient groups and clinical trials
Patient advocacy groups (PAGs) and pharma/biopharma/biotech and MedTech industries are all working towards the same goal: to improve health outcomes. And as PAGs are key stakeholders in the clinical trial...